FDA Sanctions Eli Lilly’s Easier-To-Use GLP-1 Weight Loss Pill Foundayo

FDA Sanctions Eli Lilly’s Easier-To-Use GLP-1 Weight Loss Pill Foundayo Unlike Novo Nordisk's Wegovy pill, Lilly's orforglipron pill can be ingested at a user's leisure and is not required to be taken on an empty stomach. The company "designed this to fit into people’s lives as easily as possible," a Lilly official said. Plus, a group of teens has developed a wearable device to help people with dementia track everyday tasks. https://kffhealthnews.org/morning-breakout/fda-sanctions-eli-lillys-easier-to-use-glp-1-weight-loss-pill-foundayo/